Sort by
Refine Your Search
-
for months, years, or even millennia. Our lab aims to resolve the molecular mechanisms behind this process, focusing on how promiscuous enzymes (un)intentionally transform cellular metabolites into degradation
-
The Faculty of Engineering, Department Elektronica en informatica, research group Electronics and Informatics: Research – Development - Innovation, is looking for a postdoctoral researcher. More
-
of research funding Your profile... The candidate should possess a PhD degree in Computer Science, Software Engineering or a related field The ideal candidate should have some knowledge and experience in
-
has a strong track record in exploring urology‑relevant sensory mechanisms, with translational relevance for conditions such as chronic pain, bladder dysfunction, and other urinary tract disorders
-
/microglia-based 3D models recapitulating neural-microglia interactions, using biomaterials and (micro)tissue engineering approaches. The innovative aspect of the project will be in developing new analysis
-
The Faculty of Engineering, Department Elektronica en informatica, research group Electronics and Informatics: Research – Development - Innovation, is looking for a postdoctoral researcher. More
-
record in exploring urology‑relevant sensory mechanisms, with translational relevance for conditions such as chronic pain, bladder dysfunction, and other urinary tract disorders. The urinary bladder plays
-
Department: Department of Engineering Management Regime Full-time Let’s shape the future - University of Antwerp The University of Antwerp is a dynamic, forward-thinking, European university. We
-
-scale screens to study fundamental principles in molecular and complex trait genetics using microbes as model systems. Our core technology MAGESTIC (https://doi.org/10.1038/nbt.4137 ), a CRISPR/Cas9-based
-
-scale screens to study fundamental principles in molecular and complex trait genetics using microbes as model systems. Our core technology MAGESTIC (https://doi.org/10.1038/nbt.4137 ), a CRISPR/Cas9-based